Article info

Comparative effect of metformin versus sulfonylureas with dementia and Parkinson’s disease risk in US patients over 50 with type 2 diabetes mellitus

Authors

  1. Correspondence to Dr Danielle Newby; danielle.newby{at}ndorms.ox.ac.uk
View Full Text

Citation

Newby D, Linden AB, Fernandes M, et al
Comparative effect of metformin versus sulfonylureas with dementia and Parkinson’s disease risk in US patients over 50 with type 2 diabetes mellitus

Publication history

  • Received July 12, 2022
  • Accepted August 28, 2022
  • First published September 15, 2022.
Online issue publication 
May 31, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.